New study reveals how cancer drug repotrectinib interacts with common medications
NCT ID NCT07223671
First seen Nov 03, 2025 · Last updated Jun 14, 2026 · Updated 30 times
Summary
This study looked at how repotrectinib, a cancer drug, changes the way the body processes other medications. Thirty healthy adults took repotrectinib along with a mix of common drugs like metformin and omeprazole. The goal was to measure drug levels in the blood to understand potential interactions, helping doctors prescribe safer doses in the future.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEERS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Local Institution - 0001
Daytona Beach, Florida, 32117-5116, United States
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.